WebCHIR 98014 is a highly potent and selective GSK-3 inhibitor (IC 50 values are 0.58 and 0.65 nM for the β and α isoforms, respectively). Exhibits >500-fold selectivity for GSK-3β over … WebApr 10, 2024 · chir-98014 Selective glycogen synthase kinase 3 inhibitor potentiate insulin activation of glucose transport. Menu. Home; Sample Page; April 11, 2024 Arrows …
CHIR-98014 GSK-3 Inhibitor MedChemExpress
WebAug 1, 2024 · A significant reduction in cell viability was observed after treatment with 1 μM of CHIR 98014 and BIO for 72 h. e BrdU assay of 10 μM BIO and CHIR 98014-treated H1975 cells demonstrated ... WebCHIR98014, also known as CT-98014, is a reversible, cell-permeable inhibitor of GSK3α and GSK3β (IC50 = 0.65 and 0.58 nM, respectively). It is inactive against a series of other serine/threonine or tyrosine kinases. ... CHIR-98014 is a potent, cell-permeable GSK-3 inhibitor with IC50s of 0.65 and 0.58 nM for GSK-3α and GSK-3β, respectively; it criave 2
CHIR 98014 Supplier CAS 252935-94-7 - Tocris Bioscience
Web3.根据权利要求1所述的组合物,其特征在于:糖原合成酶激酶3抑制剂选自CHIR-99021、TWS119、SB216763、CHIR-98014、Tideglusib、SB415286、LY2090314、AZD1080、3F8、L308、NSC693868、Kenpaulone, TCG24、TCS2002、FRATide, Indirubin-3’ -oxime、ARA-A014418、B10、MeB1。 WebThe use of GSK-3 inhibitors shows promising apoptotic abilities in clinical cancer treatments, particularly for lung cancer cells. This study is the first report to describe the significant … http://chir-98014.com/ criavel